Please login to the form below

Not currently logged in

Healthcare Comms news

Bmore creative renames, Kyne partners up with Agora and Oxford PharmaGenesis expands to Australia

KYNEKyne partners with Agora

Speciality health communications agency Kyne has forged a new network partnership with Agora Public Affairs and Strategic Communications, expanding its footprint to Latin America.

Agora has expertise in policy and government affairs and research and analytics and has offices located in Argentina, Columbia and Mexico.

Founder and chief executive officer, David Kyne, said: “The team at Agora represent some of the most talented communicators in Latin America and bring deep healthcare experience that will further strengthen our knowledge and skillset in the region.

“Just as importantly, we both feel like this is a great partnership from a cultural perspective.”

The new partnership will allow both group’s to combine capabilities and leverage insights across markets to inform future strategy and health programming.

Miguel Angel Herrera, Partner at Agora Public Affairs, said: “We are proud to partner with KYNE because of its leadership and commitment to the healthcare ecosystem in the US, as well as its interest to expand its global impact.”

Oxford PharmaGenesisOxford PharmaGenesis opens Australian base

Oxford PharmaGenesis has expanded its reach, opening up a new office in Melbourne, Australia.

The new office will be offering health science writing services to pharmaceutical companies and patient groups in Australia.

Chris Winchester, Global CEO at Oxford PharmaGenesis, said, “Although we are new to Australia, we already have a number of Australian clients.

“Our company is 20 years old and now numbers over 220 people in our other offices in Oxford, London, Cardiff, Basel and Philadelphia. As a result, we can bring a global perspective to local problems and are particularly proud of our award-winning Health Science approach to demonstrating evidence-based pharmaceutical value for our clients.”

Bmore Creative changes to Bmore Group

Digitally-led creative agency Bmore Creative has rebranded as Bmore Group, bringing in new pharmaceutical agency strategists and creatives to help the transition.

Headed by chief executive Ben Blackmore, the agency has a number of pharmaceutical clients including AbbVie, Allergan, Bayer, Janssen, Merck and Shire.

Blackmore said: “I am immensely proud to see Bmore Creative grow and evolve into Bmore Group.

“I truly believe that an agency must evolve with the relevant needs of patients and HCPs to provide the best service and experience to our clients.”

Article by
Gemma Jones

9th August 2018

From: Marketing


Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...